摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N1-(7-chloroquinolin-4-yl)-N3-(3-((7-chloroquinolin-4-yl)amino)propyl)-N3-methylpropane-1,3-diamine | 19418-54-3

中文名称
——
中文别名
——
英文名称
N1-(7-chloroquinolin-4-yl)-N3-(3-((7-chloroquinolin-4-yl)amino)propyl)-N3-methylpropane-1,3-diamine
英文别名
bis({3-[(7-chloroquinolin-4-yl)amino]propyl})(methyl)amine;Na(2)-(7-Chloro-4-quinolinyl)-N-[3-[(7-chloro-4-quinolinyl)amino]propyl]-N-methyl-1,3-propanediamine;N-(7-chloroquinolin-4-yl)-N'-[3-[(7-chloroquinolin-4-yl)amino]propyl]-N'-methylpropane-1,3-diamine
N1-(7-chloroquinolin-4-yl)-N3-(3-((7-chloroquinolin-4-yl)amino)propyl)-N3-methylpropane-1,3-diamine化学式
CAS
19418-54-3
化学式
C25H27Cl2N5
mdl
——
分子量
468.429
InChiKey
WYKGDIRHMPEZMN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    32
  • 可旋转键数:
    10
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    53.1
  • 氢给体数:
    2
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    4,7-二氯喹啉N,N-双(3-氨丙基)甲胺N-甲基吡咯烷酮三乙胺 作用下, 以50%的产率得到N1-(7-chloroquinolin-4-yl)-N3-(3-((7-chloroquinolin-4-yl)amino)propyl)-N3-methylpropane-1,3-diamine
    参考文献:
    名称:
    双喹啉。2.抗疟疾的N,N-双(7-氯喹啉-4-基)杂链烷二胺。
    摘要:
    合成了N,N-双(7-氯喹啉-4-基)杂烷二胺1-11,并在体外和体外对恶性疟原虫进行了筛选。这些双喹啉在体外对恶性疟原虫的IC50值为1至100 nM。与对氯喹敏感的D6克隆相比,在11种双喹啉中有6种对耐氯喹的W2克隆的效价明显更高。对于双喹啉1-11,双喹啉杂烷烃桥的长度与抗疟活性之间没有关系,并且在体内和体外抗疟活性之间也没有相关性。在体内,具有烷基醚和哌嗪桥的双喹啉比具有烷基胺桥的双喹啉对伯氏疟原虫有效。Bisquinolines 1-10是血凝素聚合的有效抑制剂,IC50值在5-20 microM的狭窄范围内,在抑制血凝素聚合的能力和抑制寄生虫生长之间存在相关性。与烷烃桥联的双喹啉相比(Vennerstrom等人,1992),这些杂烷烃桥联的双喹啉没有一个具有足够的抗疟活性,因此值得对该系列进行进一步研究。
    DOI:
    10.1021/jm9803828
点击查看最新优质反应信息

文献信息

  • Bisquinolines. 2. Antimalarial <i>N</i>,<i>N</i>-Bis(7-chloroquinolin-4-yl)heteroalkanediamines
    作者:Jonathan L. Vennerstrom、Arba L. Ager,、Arnulf Dorn、Steven L. Andersen、Lucia Gerena、Robert G. Ridley、Wilbur K. Milhous
    DOI:10.1021/jm9803828
    日期:1998.10.1
    berghei in vivo. These bisquinolines had IC50 values from 1 to 100 nM against P. falciparum in vitro. Six of the 11 bisquinolines were significantly more potent against the chloroquine-resistant W2 clone compared to the chloroquine-sensitive D6 clone. For bisquinolines 1-11 there was no relationship between the length of the bisquinoline heteroalkane bridge and antimalarial activity and no correlation
    合成了N,N-双(7-氯喹啉-4-基)杂烷二胺1-11,并在体外和体外对恶性疟原虫进行了筛选。这些双喹啉在体外对恶性疟原虫的IC50值为1至100 nM。与对氯喹敏感的D6克隆相比,在11种双喹啉中有6种对耐氯喹的W2克隆的效价明显更高。对于双喹啉1-11,双喹啉杂烷烃桥的长度与抗疟活性之间没有关系,并且在体内和体外抗疟活性之间也没有相关性。在体内,具有烷基醚和哌嗪桥的双喹啉比具有烷基胺桥的双喹啉对伯氏疟原虫有效。Bisquinolines 1-10是血凝素聚合的有效抑制剂,IC50值在5-20 microM的狭窄范围内,在抑制血凝素聚合的能力和抑制寄生虫生长之间存在相关性。与烷烃桥联的双喹啉相比(Vennerstrom等人,1992),这些杂烷烃桥联的双喹啉没有一个具有足够的抗疟活性,因此值得对该系列进行进一步研究。
  • Synthesis and in vitro antimalarial activity of a series of bisquinoline and bispyrrolo[1,2a]quinoxaline compounds
    作者:Lezanne van Heerden、Theunis T. Cloete、J. Wilma Breytenbach、Carmen de Kock、Peter J. Smith、Jaco C. Breytenbach、David D. N’Da
    DOI:10.1016/j.ejmech.2012.07.037
    日期:2012.9
    Series of bisquinolines 4–15 and bispyrrolo[1,2a]quinoxalines 16–20 containing various polyamine linkers were synthesized. The aqueous solubility and distribution coefficient were experimentally determined. The compounds were screened for antimalarial activity alongside chloroquine against D10 and Dd2 strains of Plasmodium falciparum. The growth inhibitory effects of biscompounds 4–9 were assessed
    合成了含有各种多胺连接基的一系列双喹啉4-15和双吡咯并[1,2a]喹喔啉16-20。通过实验确定了水溶性和分布系数。筛选了化合物和氯喹对恶性疟原虫的D10和Dd2菌株的抗疟活性。对多种癌细胞系评估了双化合物4–9的生长抑制作用。发现水溶性随着潜在的质子化位点的增加而增加。双喹啉8和9分别具有三亚乙基四胺和N,N'-双(3-氨基丙基)乙二胺连接基的化合物是所有合成化合物中活性最高的。发现它们对氯丹抗D10一样有效,但对Dd2菌株则更有效,对寄生细胞具有良好的选择性。含有二亚乙基三胺桥的化合物4显示了该系列中最重要的抗癌活性,并且比依托泊苷对所有三种TK10,UACC62和MCF7癌细胞系均具有更有效的抗增殖抑制剂。
  • ASYMMETRIC BISAMINOQUINOLINES AND BISAMINOQUINOLINES WITH VARIED LINKERS AS AUTOPHAGY INHIBITORS FOR CANCER AND OTHER THERAPY
    申请人:The Trustees of The University of Pennsylvania
    公开号:EP3848355A1
    公开(公告)日:2021-07-14
    The invention provides novel asymmetric and symmetric bisaminoquinolines and related compounds, methods of treatment and syntheses. The novel compounds exhibit effective anticancer activity and are useful in the treatment of a variety of autophagy-related disorders.
    本发明提供了新型不对称和对称双氨基喹啉及相关化合物、治疗方法和合成方法。这些新型化合物具有有效的抗癌活性,可用于治疗多种自噬相关疾病。
  • Potent Antimalarial Activity of Two Arenes Linked with Triamine Designed To Have Multiple Interactions with Heme
    作者:Yosuke Sakata、Kosuke Yabunaka、Yuko Kobayashi、Hirohisa Omiya、Naoki Umezawa、Hye-Sook Kim、Yusuke Wataya、Yoshimi Tomita、Yosuke Hisamatsu、Nobuki Kato、Hirokazu Yagi、Tadashi Satoh、Koichi Kato、Haruto Ishikawa、Tsunehiko Higuchi
    DOI:10.1021/acsmedchemlett.8b00222
    日期:2018.10.11
    Based on the idea that compounds designed to exhibit high affinity for heme would block hemozoin formation, a critical heme-detoxification process for malarial parasites, we synthesized a series of compounds with two pi-conjugated moieties at terminal amino groups of triamine. These compounds exhibited moderate to high antimalarial activities in vitro toward both chloroquine-sensitive and chloroquine-resistant Plasmodium falciparum. In a P. berghei-infected mouse model, 3a and 12a showed potent antimalarial activities compared to artesunate, as well as a prolonged duration of antimalarial effect. We found a good correlation between protective activity against hemin degradation and antimalarial activity. Compounds 8b and 3a strongly inhibited hemozoin formation catalyzed by heme detoxification protein.
查看更多